Is it time to re-think juvenile-onset Rheumatic and Musculoskeletal Diseases? - First steps towards individualised treatments to meet agreed targets

Clin Immunol. 2021 Feb:223:108647. doi: 10.1016/j.clim.2020.108647. Epub 2020 Dec 11.
No abstract available

Keywords: Biomarkers; Child; Classification; Inflammation; Paediatric rheumatology; Stratified; Treatment.

Publication types

  • Editorial

MeSH terms

  • Adolescent
  • Animals
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Juvenile / drug therapy*
  • Child
  • Child, Preschool
  • Humans
  • Molecular Targeted Therapy
  • Musculoskeletal Diseases / drug therapy*
  • Precision Medicine
  • Rheumatic Diseases / drug therapy*
  • Spinal Muscular Atrophies of Childhood / drug therapy*

Substances

  • Antirheumatic Agents